Eli Lilly & Co. (NYSE: LLY) last traded at $1,255.40, up 0.88% on the session. The quote above updates while this page is open; the figures below are drawn from Eli Lilly & Co.’s own filings and are restated only when a new one is published.
Eli Lilly & Co. trades on NYSE under the ticker LLY. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $1.18 trillion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Eli Lilly & Co., derived from the latest quote and its most recent SEC filing.
| Market cap | $1.18T |
|---|---|
| P/E ratio | 42.13 |
| Price / sales | 14.83 |
| Price / book | 34.88 |
| Beta | 0.34 |
Trailing-twelve-month figures tagged in Eli Lilly & Co.'s XBRL filings with the SEC.
| Revenue (TTM) | $79.67B |
|---|---|
| Net income (TTM) | $26.71B |
| EPS (TTM) | $29.80 |
| Return on equity | 78.84% |
| Cash | $8.95B |
Range and volume for LLY over the past 52 weeks.
| 52-week high | $1,292.65 |
|---|---|
| 52-week low | $694.23 |
| Volume | 1.88M |
| Average volume | 2.98M |
| Previous close | $1,244.40 |
Dividend history for Eli Lilly & Co. over the trailing twelve months.
| Dividend yield | 0.50% |
|---|---|
| Dividend per share (TTM) | $6.23 |
| Payout ratio | 20.91% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.